This study is currently not recruiting participants.

NAVIOS HYBRID flow cytometer Clinical Test

Investigation of Instrument Results for Food and Drug Administration Review

Not Recruiting
100 years or below
All
Phase N/A
1 Location

Brief description of study.

The purpose of this study is to provide instrument results for FDA review.

Detailed description of study

The purpose of this study is to provide instrument results for FDA review.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Healthy
  • Age: 100 years or below
  • Gender: All

The purpose of this study is to investigate the results of certain instruments that are being reviewed by the FDA. The study aims to understand how these instruments perform and provide necessary data for regulatory assessment.

Participants in the study will undergo various procedures to test the instruments. These procedures are designed to ensure that the instruments are functioning correctly and provide accurate results. The study will collect data from these procedures for analysis.

  • Who can participate: Eligibility criteria are not specified.
  • Study details: Participants will be involved in testing procedures that assess the performance of certain instruments. The data collected from these tests will be analyzed for accuracy and reliability. No placebo is involved, as only instrument testing is conducted.
Updated on 19 Feb 2024. Study ID: 1509079100

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team